Why Treatment Time Is Not the Same as UVB Dose in Home Phototherapy

Two people use home UVB phototherapy devices for exactly 60 seconds.

One device delivers an irradiance of 2 mW/cm². The other delivers 4 mW/cm².

The treatment time is identical, but the theoretical doses are not:

• 2 mW/cm² × 60 seconds = 120 mJ/cm²

• 4 mW/cm² × 60 seconds = 240 mJ/cm²

The second exposure delivers twice as much UVB energy in the same amount of time.

This simple example explains one of the most important—and most commonly misunderstood—principles of home narrowband UVB treatment:

Treatment time is only one part of the dose.

A timer shows how long the lamps remain on. It does not, by itself, show how much ultraviolet energy reaches each square centimetre of skin. That depends on the irradiance at the treatment surface, as well as treatment distance, lamp output, device design, positioning, angle and maintenance.

This is why copying another person’s UVB treatment time can be unsafe, even when both people use a 311 nm home phototherapy device. It is also why a schedule created for one machine should not automatically be transferred to another.

The clock matters—but only when the rest of the dose equation remains controlled.

Why UVB Treatment Time Alone Does Not Tell You the Dose

In phototherapy, UVB dose is generally expressed as energy delivered per unit area, commonly in millijoules per square centimetre:

Dose (mJ/cm²) = Irradiance (mW/cm²) × Time (seconds)

The formula is straightforward. Applying it safely in real treatment is more complicated.

Irradiance describes the rate at which UVB energy reaches the skin. A device with higher irradiance can deliver a prescribed UVB phototherapy dose in less time than a lower-output device.

For example:

The example is deliberately simple. Actual treatment also depends on how the device was tested, the distance from the skin, the treatment geometry, lamp condition and whether output is actively monitored.

The key point is that “60 seconds” has no universal phototherapy meaning.

It only becomes meaningful when the following are known:

• the exact home phototherapy device

• its irradiance under the specified test conditions

• the required treatment distance

• the treatment area

• the positioning method

• the condition of the light source

• whether treatment is controlled by time or dose

• the clinical schedule prescribed for the patient

A clinic may prescribe treatment in seconds because it has already translated a target dose into the appropriate exposure time for a specific machine.

That does not make time equivalent to dose. It means the time is valid only within the conditions used to calculate it.

Change the device, output, distance or lamp condition, and the meaning of that time can change.

What Changes the Dose Delivered by Home UVB Phototherapy?

Several variables affect the amount of UVB energy delivered during a home treatment session. Some are obvious. Others are easily overlooked.

1. Irradiance

Irradiance is the most direct reason the same UVB treatment time can produce different doses.

Two devices may both use narrowband UVB light around 311–313 nm but deliver different irradiance at the treatment surface. Differences can result from:

• lamp type and quantity

• reflector design

• electrical control

• treatment aperture

• device geometry

• treatment distance

• output regulation

• lamp condition

A higher-output system may deliver a prescribed dose more quickly. A lower-output device may need a longer exposure to deliver the same energy per square centimetre.

This is why wavelength alone does not determine treatment time.

Two devices being described as “311 nm UVB” does not mean they:

• produce the same irradiance

• require the same treatment time

• deliver the same dose at the same distance

• can use interchangeable treatment schedules

Wavelength describes the spectral region being delivered. Irradiance describes how quickly energy reaches the skin.

They answer different questions.

2. Treatment Distance

Distance can change the irradiance reaching the treatment area.

A handheld home phototherapy device may be designed to:

• touch the skin through a spacer

• remain a fixed distance away

• use a comb attachment to create consistent spacing

• be held over a defined treatment field

A larger home panel may require the patient to stand at a marked distance.

If the spacing changes from one session to the next, the exposure may also change. Moving closer to the lamp because it “feels more effective” can increase exposure. Holding the device farther away may reduce it.

Body position matters too. Leaning toward a panel, rotating the body or treating curved areas can change how evenly UVB reaches the skin.

This makes positioning guidance part of dose consistency—not merely a convenience feature.

3. Lamp Output and Operating Condition

Phototherapy lamps do not necessarily maintain identical output throughout their entire service life.

Lamp age, operating temperature, voltage and system condition may affect output or the time required to deliver a target dose. Mature phototherapy systems manage this issue in different ways.

Some systems:

• track lamp operating hours

• require periodic output checks

• specify calibration intervals

• provide lamp replacement guidance

• use integrated dosimetry to measure output during treatment

• automatically adjust treatment time to reach a selected dose

A time-controlled device relies on a sufficiently predictable relationship between lamp output and exposure time under the stated operating conditions.

A dose-controlled system may monitor light output and alter the treatment duration required to reach the entered dose.

Neither method removes the need for correct positioning, maintenance and professional instructions.

If treatment appears less effective, the safe response is not simply to add more seconds. The clinic may need to consider:

• adherence

• positioning

• missed sessions

• treatment-area coverage

• diagnosis and disease activity

• medication changes

• lamp performance

• device maintenance

• the treatment plan itself

More time is not a substitute for finding the cause.

4. Treatment Area, Angle and Overlap

Treating a flat area is different from treating an irregular or curved surface.

Uniform coverage can be more difficult on:

• elbows

• knees

• fingers

• toes

• hands and feet

• ankles

• scalp margins

• ears

• curved facial areas

• irregular plaques

A handheld home phototherapy device may require a large lesion to be divided into multiple fields. If those fields overlap, the overlapping skin may receive additional exposure. If gaps remain, parts of the lesion may receive less.

Treatment angle also affects coverage. Light directed more consistently toward the treatment surface is easier to reproduce than light applied from changing oblique angles.

Patients do not need to calculate geometric angles. They do need a positioning method that can be repeated consistently.

For clinics and distributors, this creates an important equipment question:

Does the device design help the user reproduce the same distance, angle and treatment field during every session?

5. Skin Response

Skin response is an important clinical signal, but it is often misinterpreted.

Common assumptions include:

• no redness means the dose was too low

• stronger redness means better treatment

• burning proves the device is effective

• no immediate reaction means the next treatment can be increased

None of these assumptions should guide unsupervised dose changes.

Professional NB-UVB protocols may use erythema response to determine whether a dose should be increased, maintained, reduced or withheld. The decision depends on:

• the severity of the reaction

• how long it lasts

• whether it is painful

• the treated body area

• skin phototype

• diagnosis

• previous dose

• the clinical protocol

The reaction may also be delayed. Skin that appears normal immediately after treatment may become red several hours later.

This is why users should record not only what happened during treatment but also how the skin looked and felt later that day and the following day.

Mild temporary pinkness is different from persistent redness, tenderness, swelling, burning pain or blistering. The response to each should follow the prescribed protocol, not an improvised increase or reduction.

6. Missed Treatment Sessions

A home phototherapy schedule assumes a particular treatment frequency.

After an interruption, the skin may no longer have the same recent UV exposure and adaptation. Automatically resuming the previous dose or treatment time may therefore be inappropriate.

Professional phototherapy protocols commonly include missed-treatment rules, but those rules are not identical everywhere. The next step may depend on:

• the number of missed sessions

• the length of the interruption

• the previous dose

• recent erythema

• diagnosis

• treatment protocol

• clinical judgment

Depending on the situation, the patient may be instructed to:

• repeat the previous dose

• reduce the next dose

• return to an earlier treatment level

• restart more cautiously

• contact the treating clinic before continuing

The lesson is not to memorise a universal reduction percentage.

It is:

Do not automatically resume the previous UVB treatment time after a significant interruption unless the prescribed protocol clearly tells you to do so.

Why Copying Another Patient's Treatment Schedule Can Go Wrong

Online patient communities often include questions such as:

• “How many seconds do you use?”

• “We both have vitiligo—should our schedules be the same?”

• “My friend uses 90 seconds, so why was I told to start lower?”

• “Both lamps are 311 nm. Why are the treatment times different?”

These are understandable questions, but they assume that time can be separated from the treatment context.

It cannot.

Two patients receiving NB-UVB phototherapy may differ in:

• device irradiance

• device-to-skin distance

• lamp condition

• treatment field

• skin phototype

• diagnosis

• lesion location

• previous UV exposure

• photosensitising medications

• erythema sensitivity

• treatment interruption history

• clinician-selected starting dose

• dose-increase protocol

Even two people using the same device model for the same condition may not receive the same home phototherapy treatment schedule.

One may be treating a thick plaque on an elbow. Another may be treating thinner facial skin. One may have completed several well-tolerated sessions. Another may be restarting after an interruption.

A schedule is not merely a number of seconds.

It represents a specific combination of:

• device

• output

• treatment area

• patient response

• treatment history

• clinical plan

That combination cannot safely be copied from an online comment.

What Skin Response Can—and Cannot—Tell You About UVB Dose

Skin response can help clinicians evaluate treatment tolerance. It should not become a home dose calculator.

No visible redness

No redness after a session does not automatically mean that the treatment was ineffective or that the next exposure should be increased substantially.

NB-UVB treatment response develops over a course of treatment. It should not be judged from a single session.

Any increase should follow the prescribed schedule.

Mild temporary pinkness

Some protocols distinguish mild, short-lived and asymptomatic pinkness from a more significant phototoxic reaction.

Whether treatment should be increased, maintained or modified depends on the protocol. Patients should not create their own thresholds based on appearance alone.

Persistent redness or tenderness

Redness that lasts longer than expected, becomes tender, feels hot or causes discomfort may indicate excessive exposure.

The next session should not proceed automatically without following the treatment instructions or contacting the supervising clinical team.

Blistering, swelling or severe pain

Blistering, marked swelling, severe pain or a burn-like reaction requires treatment interruption and professional advice.

These reactions are not evidence that therapy is “working better.”

A stronger visible reaction does not automatically produce a better clinical result.

What to Record After Every Home Phototherapy Session

A simple treatment record can prevent avoidable errors and help the treating team understand what happened if a reaction, interruption or lack of progress occurs.

A useful phototherapy treatment log should include:

Date and time

This documents treatment frequency and identifies missed sessions.

Device used

This is important if equipment changes during the treatment course. A time prescribed for one home phototherapy device should not automatically be applied to another.

Treatment area

Different body areas may have different instructions or limits.

Prescribed dose or treatment time

Record the exact value delivered rather than relying on memory.

Positioning method

For example:

• device placed against a spacer

• comb attachment used

• fixed standing mark

• contact frame

• specified device-to-skin distance

Protective measures

Record whether protective goggles and shielding of uninvolved areas were used as instructed.

Skin response

Check the treatment area later and record:

• no visible reaction

• mild temporary pinkness

• persistent redness

• tenderness

• burning

• swelling

• blistering

Missed sessions

Record treatment interruptions accurately.

Medication or topical-product changes

Some medications and topical products may alter photosensitivity. Changes should be discussed with the treating professional.

Technical problems

Record unusual events such as:

• lamp error

• damaged spacer

• cracked treatment window

• timer malfunction

• interrupted exposure

• unexpectedly long treatment

• suspected output change

A treatment log does not replace clinical review. It makes that review more useful.

What Should Happen After Missed Home Phototherapy Sessions?

Missing several sessions changes more than the calendar.

Treatment intervals form part of the dosing protocol. This is why clinical phototherapy programs commonly include procedures for treatment interruptions.

The unsafe approach is:

“I tolerated the old treatment time before, so I will restart at the same level.”

The correct next step depends on the prescribed protocol.

Following an interruption, the patient may need to:

• repeat the previous treatment

• reduce the next exposure

• return to an earlier dose level

• restart cautiously

• request clinical review

Longer interruptions generally require more caution than a single delayed session, but there is no universal rule that should be applied to every patient, diagnosis and device.

A well-organised home UVB phototherapy program should explain in advance:

• what counts as a missed treatment

• when the next exposure needs adjustment

• when treatment should be paused

• when the clinic must be contacted

• whether the device restricts treatment frequency or access

Patients should not need to search for improvised dosing advice after an interruption occurs.

Time-Controlled vs Dose-Controlled Home Phototherapy Devices

Home phototherapy devices may manage exposure through treatment time, target dose or a guided control system.

Understanding the difference helps clinics and distributors explain the equipment accurately.

Time-controlled devices

In a time-controlled phototherapy device, the user enters or receives an exposure time. The lamps remain on for that period and then switch off.

This is straightforward, but the scheduled time remains linked to:

• the output of that model

• the treatment distance

• lamp condition

• treatment area

• prescribed protocol

A timed treatment is therefore device-specific.

It is reliable only when the relationship between output, positioning and time remains adequately controlled.

Dose-controlled devices

In a dose-controlled phototherapy device, the treatment target is entered in mJ/cm² for UVB.

An integrated dosimetry system may measure lamp output and automatically adjust treatment duration to deliver the selected energy dose. This can help compensate for changes associated with lamp output and operating conditions.

Dose control still depends on:

• sensor accuracy

• calibration

• system maintenance

• treatment geometry

• correct positioning

• correct dose entry

• software and hardware performance

Dose-controlled does not mean self-prescribed. The target UVB phototherapy dose still needs to come from an appropriate clinical treatment plan.

Guided treatment systems

Some home systems include:

• access codes

• maximum exposure limits

• treatment counters

• limited treatment sessions

• guided dose progression

• physician-controlled prescriptions

• previous-treatment records

These features do not replace the clinician.

Their purpose is to help the equipment reproduce a prescribed treatment workflow and reduce unintended changes.

What Clinics Should Check Before Recommending a Home Phototherapy Device

A home phototherapy device should not be selected only by wavelength, lamp count, price or appearance.

Clinics should evaluate how the system manages dose, time, output and user behaviour.

Is irradiance clearly specified?

The information should explain how output is defined and under what measurement conditions.

An irradiance figure without a treatment distance or measurement method can be difficult to interpret.

Is the treatment distance reproducible?

Useful design features may include:

• fixed spacers

• comb attachments

• contact frames

• clearly marked standing positions

• model-specific positioning instructions

Does the device control time, dose or both?

The clinic should understand whether the treatment plan will be prescribed in seconds or mJ/cm² and how the device manages that value.

Are exposure limits available?

Depending on the use case, valuable controls may include:

• maximum treatment time

• treatment counters

• access codes

• physician-issued treatment codes

• session limits

• lockout functions

• treatment history

Can lamp use and maintenance be tracked?

Lamp-hour tracking, calibration guidance, maintenance schedules and replacement instructions can reduce uncertainty as the equipment ages.

Are missed-session instructions included?

Users need a clear process for treatment interruptions rather than relying on guesswork.

Are erythema instructions specific?

Instructions should explain what to do after:

• mild temporary redness

• persistent erythema

• tenderness

• burning

• swelling

• blistering

Generic advice to “increase gradually” is not enough.

Are the required protective accessories provided?

Depending on the device, these may include:

• UV protective goggles

• shields for unaffected skin

• comb attachments

• spacers

• blackout covers

• positioning accessories

Is treatment history available?

A timer alone may not provide sufficient information when clinicians need to review adherence, interruptions or reactions.

Are the instructions model-specific?

A general NB-UVB leaflet should not replace instructions written for the exact home phototherapy device.

The manual should explain the real controls, positioning method, safety limits, maintenance and treatment workflow of that model.

What Distributors Should Explain to Buyers

Distributors should avoid reducing home UVB phototherapy to a short list of familiar selling points:

• 311 nm

• portable

• digital timer

• simple operation

• suitable for vitiligo and psoriasis

These features may be relevant, but they do not explain whether the device can support consistent treatment.

A stronger product discussion should cover:

• whether exposure is controlled by time or dose

• how irradiance is defined

• how treatment distance is maintained

• whether lamp use is tracked

• what exposure limits are available

• whether treatment history can be reviewed

• how interruptions are handled

• which accessories support repeatable positioning

• what user training is provided

• what after-sales and maintenance support is available

Distributors should never suggest that all 311 nm devices can share the same treatment schedule.

Such a claim would ignore differences in:

• irradiance

• treatment geometry

• lamp configuration

• distance

• control method

• clinical protocol

A home phototherapy device should help the patient reproduce a prescribed treatment safely and consistently.

It should not encourage the patient to invent the prescription.

When Home UVB Treatment Should Be Paused

A home treatment program should define clear stopping points.

Treatment should not continue automatically when the user experiences:

• significant or persistent erythema

• increasing tenderness

• burning pain

• blistering

• swelling

• an unexpected rash

• accidental eye exposure

• device malfunction

• uncertainty about the treatment entry

• a substantial treatment interruption

• a new potentially photosensitising medication

• uncertainty about whether a dose has already been delivered

The specific response should follow the prescribed protocol and the supervising clinician’s instructions.

The general principle is simple:

When the treatment conditions are unclear, adding more UV exposure is not the safe way to find the answer.

Conclusion: The Clock Matters Only When the Rest of the Dose Equation Is Controlled

Treatment time is highly visible. That is why it is easy to treat it as the most important number.

But in home UVB phototherapy, time is only a delivery parameter.

The actual dose depends on the energy reaching the skin. That relationship is shaped by irradiance, device output, treatment distance, lamp condition, positioning, treatment area, control mode and adherence to the prescribed schedule.

This leads to several practical conclusions:

• The same 60 seconds can deliver different doses on different devices.

• A treatment time should not be copied from another patient.

• A schedule should not automatically be transferred to another device.

• Missed sessions may change the next treatment.

• Skin redness should not become an unsupervised dose calculator.

• Device design should support repeatable positioning and exposure control.

• Home phototherapy should remain connected to professional guidance.

A timer can tell the user when the lamps will switch off.

A well-designed treatment system should help ensure that the time entered still represents what the treatment plan intended.

FAQ

Is UVB treatment time the same as UVB dose?

No. Treatment time is the duration of exposure. UVB dose is the energy delivered per unit area, usually expressed in mJ/cm². The dose depends on irradiance as well as time.

How is UVB phototherapy treatment time calculated?

In principle, treatment time can be calculated from the target dose and irradiance at the treatment surface. In practice, patients should not calculate or alter their own schedule because device output, treatment distance, positioning, skin response and the clinical protocol also matter.

Can two 311 nm home phototherapy devices use the same treatment time?

Not necessarily. They may have different irradiance, lamp configurations, reflectors, treatment distances and control systems. The same wavelength does not guarantee the same dose during the same exposure time.

Does UVB lamp output affect treatment time?

Yes. Higher irradiance can deliver a target dose in less time, while lower irradiance may require a longer exposure. Lamp output may also change with use and operating conditions.

Does treatment distance affect UVB dose?

Yes. Changing the distance between the light source and skin can change the irradiance reaching the treatment area. Users should follow the positioning instructions for the exact device.

Can treatment time be increased when there is no redness?

Not automatically. No visible redness after one session does not prove the dose was too low. Dose progression should follow the prescribed treatment protocol.

What should happen after missed home phototherapy sessions?

The previous treatment time should not automatically be resumed after a significant interruption. Patients should follow the missed-treatment instructions provided by the clinic or the model-specific treatment program.

What is the difference between time-controlled and dose-controlled phototherapy?

A time-controlled device operates for a selected duration. A dose-controlled device targets an energy dose and may adjust treatment time according to measured lamp output. Both approaches require correct use, maintenance and professional treatment instructions.

What should be recorded in a home phototherapy treatment log?

Record the date, device, treatment area, prescribed dose or time, positioning method, protective measures, skin response, missed sessions, medication changes and technical problems.

Is home UVB phototherapy safe without medical supervision?

Home UVB phototherapy should be used under professional guidance and according to the instructions for the prescribed device. It should not become unsupervised trial-and-error UV exposure.

References

[1] British Association of Dermatologists. Phototherapy – NB-UVB. Patient information on narrowband UVB treatment, treatment delivery, potential reactions, and safety considerations.
https://www.bad.org.uk/pils/phototherapy-nb-uvb/

[2] British Association of Dermatologists and British Photodermatology Group. British Association of Dermatologists and British Photodermatology Group Guidelines for Narrowband Ultraviolet B Phototherapy 2022.
https://bpg.org.uk/wp-content/uploads/2023/10/BAD-and-BPG-guidelines-for-narrowband-UVB-phototherapy-2022.pdf

[3] NHS Scotland Photonet. Treatment Protocols: Narrowband UVB Phototherapy. Clinical protocols covering UVB dose recording, erythema response, dose progression, and treatment interruptions.
https://cdn.bad.org.uk/uploads/2023/03/19174136/NSD610-008.05-Photonet-Treatment-Protocols.pdf

[4] DermNet New Zealand. UVB Phototherapy. Clinical overview of narrowband UVB treatment, dose measurement, treatment schedules, and erythema-based dose adjustment.
https://dermnetnz.org/cme/phototherapy/uvb-phototherapy

[5] DermNet New Zealand. Home Phototherapy. Overview of home phototherapy equipment, treatment supervision, dose management, and device safety features.
https://dermnetnz.org/topics/home-phototherapy

[6] DermNet New Zealand. Phototesting. Overview of minimal erythema dose testing and assessment of skin response to ultraviolet exposure.
https://dermnetnz.org/topics/phototesting

[7] Daavlin. ClearLink Home-Control Operation Manual. Device documentation covering timed, dosimetric, and physician-guided treatment modes, exposure limits, and maintenance requirements.
https://daavlin.com/wp-content/uploads/2024/01/MNL-00006-6-7-Series-ClearLink-Manual.pdf

[8] Daavlin. M Series ClearLink Operation Manual. Instructions covering home phototherapy treatment entry, dosimetry, positioning, treatment control, and system maintenance.
https://daavlin.com/wp-content/uploads/2024/01/MNL-00005-4-M-Series-ClearLink-Manual.pdf

[9] Daavlin. DT Home-Control Operation Manual. Documentation covering treatment controls, maximum exposure settings, lamp-hour tracking, and home phototherapy safety requirements.
https://daavlin.com/wp-content/uploads/2024/01/MNL-00049-1-1-Series-DT-Operation-Manual.pdf

[10] Phothera. Panosol 3D Home Phototherapy System. Technical information on integrated dosimetry, real-time lamp-output measurement, and compensation for changes associated with lamp age, room temperature, and line voltage.
https://www.natbiocorp.com/home-phototherapy/panosol-6-3d/